California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

Press releases published on July 24, 2026

Jul. 24, 2026

LifeMD to Report Second Quarter 2026 Financial Results on August 5

Indeterminate GlobeNewswire

Jul. 24, 2026

Outlook Therapeutics Announces LYTENAVA™ FDA Approval as the First and Only FDA-Approved Ophthalmic Bevacizumab for the Treatment of Wet AMD

Indeterminate GlobeNewswire

Jul. 24, 2026

Affidea beschleunigt Wachstum in Großbritannien durch strategische Partnerschaft mit LIPS Healthcare

Indeterminate GlobeNewswire

Jul. 24, 2026

Affidea accélère sa croissance au Royaume-Uni en signant un partenariat stratégique avec LIPS Healthcare

Indeterminate GlobeNewswire

Jul. 24, 2026

HorseFil Official Launch 2026 Effective Men's Energy and Vitality Gummies Highlights Ingredient, Supplement Facts Available in USA

Indeterminate GlobeNewswire

Jul. 24, 2026

Nordic Naturals Releases Expert Insights on Why Omega-3s Should Be on Back-to-School Checklists

Indeterminate GlobeNewswire

Jul. 24, 2026

Robotic Radical Prostatectomy Comes Up ‘Short’ in CAPTAIN Trial

Indeterminate GlobeNewswire

Jul. 24, 2026

AI-Powered Wound Care Market Poised for Revolutionary Disruption as Investment Activity Surges

Indeterminate GlobeNewswire

Jul. 24, 2026

Allsup Highlights SSDI Barriers And Progress On ADA’s 36th Anniversary

Indeterminate GlobeNewswire

Jul. 24, 2026

Dr. Ekta Pandya Named Fellow of Pierre Fauchard Academy, Recognized for Leadership in Dentistry and Children's Oral Health

Indeterminate GlobeNewswire

Jul. 24, 2026

WellSpan Health Awarded $2.8 million to Strengthen Care at Rural Hospitals

Indeterminate GlobeNewswire

Jul. 24, 2026

Ernexa Therapeutics CEO Corner Emphasizes How ERNA-101 Could Help Unlock the Next Generation of Combination Cancer Therapies

Indeterminate GlobeNewswire

Jul. 24, 2026

Subcutaneous PD-1 Inhibitors Transition from Novelty to Routine Care as Oncologists Tailor Use by Tumor Type, According to Spherix Global Insights

Indeterminate GlobeNewswire

Jul. 24, 2026

Case Management Organizations Partner Again to Recognize Case Managers

Indeterminate GlobeNewswire

Jul. 24, 2026

Surgery Partners Announces Entry Into Agreement to Sell Ownership Interests in Idaho Falls Facilities to Intermountain Health; Reaffirms Guidance, Excluding Impact of Transaction

Indeterminate GlobeNewswire

Jul. 24, 2026

hear.com Honored as Gold Stevie® Award Winner in 2026 Stevie Awards for Technology Excellence

Indeterminate GlobeNewswire

Jul. 24, 2026

NEZGLYAL® (leriglitazone) receives a positive CHMP opinion for the treatment of cerebral Adrenoleukodystrophy (cALD), a rare neurodegenerative disease

Indeterminate GlobeNewswire

Jul. 24, 2026

Autonomix Medical Demonstrates Renal Nerve Sensing and Neural Activity Change in Preclinical Study

Indeterminate GlobeNewswire

Jul. 24, 2026

Magnendo Secures $18M Series A Financing to Transform Endovascular Access for Stroke Intervention

Indeterminate GlobeNewswire

Jul. 24, 2026

Amwell® to report second quarter 2026 operating results

Indeterminate GlobeNewswire